CollPlant Biotechnologies Ltd - Ordinary Shares New
NASDAQ:CLGN 3:38:05 PM EDT
| Market Cap (Intraday) | 61.74M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.25 |
| 50-Day MA | $4.91 |
| 200-Day MA | $5.34 |
CollPlant Biotechnologies Ltd - Ordinary Shares New Stock, NASDAQ:CLGN
Weizmann Science Park, 4 Oppenheimer Street, Rehovot, Tel Aviv 7670104
Israel
Phone: +972.73.232.5600
Number of Employees: 75
Description
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.